For the quarter ending 2026-03-31, OCUL made $10,785K in revenue. -$88,612K in net income. Net profit margin of -821.62%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue, net | 10,785 | 13,250 | 14,544 | 13,459 |
| Cost of product revenue | 1,329 | 1,594 | 1,774 | 1,944 |
| Research and development | 66,213 | 50,800 | 52,358 | 51,081 |
| Selling and marketing | 16,577 | 12,957 | 13,088 | 13,729 |
| General and administrative | 20,006 | 17,660 | 16,022 | 14,346 |
| Total costs and operating expenses | 104,125 | 83,011 | 83,242 | 81,100 |
| Loss from operations | -93,340 | -69,761 | -68,698 | -67,641 |
| Interest income | 6,050 | 7,345 | 3,729 | 3,455 |
| Interest expense | 2,777 | 2,833 | 3,002 | 3,016 |
| Change in fair value of derivative liabilities | 1,455 | 595 | -1,447 | -641 |
| Gain on disposal of items of property and equipment | - | - | - | 29 |
| Other gains (expenses) | - | 0 | - | - |
| Total other income (expense), net | 4,728 | 5,107 | -720 | -173 |
| Net loss | -88,612 | -64,654 | -69,418 | -67,814 |
| Basic EPS | -0.4 | -0.29 | -0.38 | -0.39 |
| Diluted EPS | -0.4 | -0.29 | -0.38 | -0.39 |
| Basic Average Shares | 224,099,410 | 223,054,473 | 183,919,808 | 172,594,662 |
| Diluted Average Shares | 224,099,410 | 223,054,473 | 183,919,808 | 172,594,662 |
OCULAR THERAPEUTIX, INC (OCUL)
OCULAR THERAPEUTIX, INC (OCUL)